T-CELL LEUKEMIA/LYMPHOMA, ADULT
Clinical trials for T-CELL LEUKEMIA/LYMPHOMA, ADULT explained in plain language.
Never miss a new study
Get alerted when new T-CELL LEUKEMIA/LYMPHOMA, ADULT trials appear
Sign up with your email to follow new studies for T-CELL LEUKEMIA/LYMPHOMA, ADULT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New trial aims to stop a deadly cancer before it starts
Prevention Recruiting nowThis phase 2 study tests whether the drug mogamulizumab can prevent adult T-cell leukemia/lymphoma (ATL) in people infected with HTLV-1 who are at high risk. About 134 participants will receive low doses of the drug over several weeks. The goal is to see if it can reduce the viru…
Matched conditions: T-CELL LEUKEMIA/LYMPHOMA, ADULT
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Prevention
Last updated Jun 23, 2026 11:58 UTC
-
Scientists target cancer's weak spot: oxygen balance
Knowledge-focused Recruiting nowThis study looks for better ways to treat T-cell leukemia and lymphoma, a type of blood cancer. Researchers will test combinations of drugs that affect how cells handle oxygen-related stress, aiming to kill cancer cells while sparing healthy ones. The study involves 120 adults an…
Matched conditions: T-CELL LEUKEMIA/LYMPHOMA, ADULT
Sponsor: Istituto Oncologico Veneto IRCCS • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:07 UTC